STAT October 18, 2024
Elizabeth Cooney

Executives cite challenges and hopeful signs on obesity and Alzheimer’s treatment

What do Amgen, Biogen, and Takeda have in common?

Leaders of research and development at the three biopharma companies shared a stage Thursday at the STAT...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
GLP-1 drug coverage for obesity making inroads with large employers: Mercer

Share This Article